timolol has been researched along with Cancer Syndromes, Hereditary in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elmazar, HF; Khairy, HA; Mandour, SS; Marey, HM | 1 |
| Gummi, R; Marsh, JD; Stahl, ED | 1 |
| Kazandjieva, J; Semkova, K | 1 |
| Hu, L; Huang, HZ; Li, W; Li, X; Lin, XX | 1 |
| Bayart, CB; Brandling-Bennett, HA | 1 |
| Hildebrand, GD; Painter, SL | 1 |
| Ariwibowo, L; Budiyanto, A; Danarti, R; Radiono, S | 1 |
| Burón, I; Calvo, M; Fueyo-Casado, A; Garcia-Millán, C; Villegas, C | 1 |
1 review(s) available for timolol and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
Beta-blockers for childhood vascular tumors.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Atenolol; Child, Preschool; Facial Neoplasms; Humans; Infant; Neoplastic Syndromes, Hereditary; Neurocutaneous Syndromes; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome; Vascular Neoplasms | 2015 |
2 trial(s) available for timolol and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Drug Therapy, Combination; Eye Neoplasms; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Neoplasm Staging; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Propranolol; Retrospective Studies; Time Factors; Timolol; Treatment Outcome | 2018 |
Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
Topics: Aminoquinolines; Antineoplastic Agents; Extremities; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Imiquimod; Infant; Male; Neoplastic Syndromes, Hereditary; Non-Randomized Controlled Trials as Topic; Ointments; Ophthalmic Solutions; Skin Neoplasms; Timolol; Torso | 2015 |
5 other study(ies) available for timolol and Cancer Syndromes, Hereditary
| Article | Year |
|---|---|
Topical timolol for an iris hemangioma.
Topics: Administration, Ophthalmic; Adrenergic beta-Antagonists; Female; Hemangioma, Capillary; Humans; Infant; Iris Neoplasms; Magnetic Resonance Imaging; Microscopy, Acoustic; Neoplastic Syndromes, Hereditary; Timolol | 2018 |
Rapid complete regression of an early infantile hemangioma with topical timolol gel.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Gels; Head and Neck Neoplasms; Hemangioma, Capillary; Humans; Infant; Male; Neoplastic Syndromes, Hereditary; Scalp; Skin Neoplasms; Timolol; Treatment Outcome | 2014 |
Topical timolol maleate 0.5% solution for the management of deep periocular infantile hemangiomas.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Amblyopia; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Orbital Neoplasms; Retrospective Studies; Timolol | 2016 |
Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Female; Gels; Hemangioma, Capillary; Humans; Infant; Male; Neoplastic Syndromes, Hereditary; Prospective Studies; Solutions; Timolol; Treatment Outcome | 2016 |
Topical timolol for infantile hemangioma of the eyelid.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Eyelid Neoplasms; Hemangioma, Capillary; Humans; Infant, Newborn; Male; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Timolol | 2013 |